Frontiers of Medicine
>> 2018,
Volume 12,
Issue 6
doi:
10.1007/s11684-017-0583-y
REVIEW
Platelet membrane-based and tumor-associated platelet- targeted drug delivery systems for cancer therapy
1. College of Pharmaceutical Science, Jilin University, Changchun 130021, China
2. CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China
3. University of Chinese Academy of Sciences, Beijing 100049, China |
Accepted: 2018-04-09
Available online: 2018-12-03
Next
Previous
Abstract
Platelets have long been known to play critical roles in hemostasis by clumping and clotting blood vessel injuries. Recent experimental evidence strongly indicates that platelets can also interact with tumor cells by direct binding or secreting cytokines. For example, platelets have been shown to protect circulating cancer cells in blood circulation and to promote tumor metastasis. In-depth understanding of the role of platelets in cancer progression and metastasis provides promising approaches for platelet biomimetic drug delivery systems and functional platelet-targeting strategies for effective cancer treatment. This review highlights recent progresses in platelet membrane-based drug delivery and unique strategies that target tumor-associated platelets for cancer therapy. The paper also discusses future development opportunities and challenges encountered for clinical translation.
京公网安备 11010502051620号
